Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
18
QDEL Quote, Financials, Valuation and Earnings
Last price:
$21.55
Seasonality move
:
0.34%
Day range:
$20.92 - $21.80
52-week range:
$19.50 - $41.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.53x
P/B ratio:
0.75x
Volume:
572.7K
Avg. volume:
1.3M
1-year change:
-45.62%
Market cap:
$1.4B
Revenue:
$2.7B
EPS (TTM):
-$16.66
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
QDEL
QuidelOrtho Corp.
|
$700.1M | $0.42 | -1.6% | 480.41% | $39.17 |
|
ATRC
AtriCure, Inc.
|
$139.8M | -$0.04 | 12.89% | -57.61% | $49.38 |
|
BSX
Boston Scientific Corp.
|
$5.3B | $0.78 | 11.29% | 75.65% | $104.24 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.8B | $2.27 | 16.31% | 10.87% | $609.82 |
|
ITGR
Integer Holdings Corp.
|
$462.7M | $1.70 | -2.22% | 88.24% | $92.63 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.2M | -$0.04 | 22.78% | -97.49% | $5.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
QDEL
QuidelOrtho Corp.
|
$21.19 | $39.17 | $1.4B | -- | $0.00 | 0% | 0.53x |
|
ATRC
AtriCure, Inc.
|
$30.99 | $49.38 | $1.5B | -- | $0.00 | 0% | 2.77x |
|
BSX
Boston Scientific Corp.
|
$72.21 | $104.24 | $107.2B | 37.24x | $0.00 | 0% | 5.38x |
|
ISRG
Intuitive Surgical, Inc.
|
$501.18 | $609.82 | $178B | 63.63x | $0.00 | 0% | 18.06x |
|
ITGR
Integer Holdings Corp.
|
$86.03 | $92.63 | $3B | 29.98x | $0.00 | 0% | 1.64x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.31 | $5.50 | $42.4M | -- | $0.00 | 0% | 4.95x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
QDEL
QuidelOrtho Corp.
|
59.61% | 1.712 | 146.07% | 0.74x |
|
ATRC
AtriCure, Inc.
|
13.46% | 1.893 | 3.88% | 2.88x |
|
BSX
Boston Scientific Corp.
|
33.07% | 0.600 | 8.45% | 0.94x |
|
ISRG
Intuitive Surgical, Inc.
|
0.95% | 0.975 | 0.08% | 3.73x |
|
ITGR
Integer Holdings Corp.
|
43% | -0.766 | 48.92% | 2.05x |
|
PSTV
Plus Therapeutics, Inc.
|
0.41% | -3.087 | 0.02% | 1.22x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
QDEL
QuidelOrtho Corp.
|
$274.6M | -$37.5M | -21.29% | -44.45% | -5.19% | $86.6M |
|
ATRC
AtriCure, Inc.
|
$104.6M | $3.5M | -2.09% | -2.44% | 2.49% | $18.4M |
|
BSX
Boston Scientific Corp.
|
$3.6B | $1.2B | 8.3% | 12.55% | 22.93% | $1B |
|
ISRG
Intuitive Surgical, Inc.
|
$1.9B | $864.3M | 16.53% | 16.59% | 30.16% | $730M |
|
ITGR
Integer Holdings Corp.
|
$106.1M | $51.1M | 3.47% | 6.11% | 10.86% | $27.9M |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$4.5M | -- | -- | -320.83% | -$2.6M |
QuidelOrtho Corp. vs. Competitors
-
Which has Higher Returns QDEL or ATRC?
AtriCure, Inc. has a net margin of -18.07% compared to QuidelOrtho Corp.'s net margin of 1.25%. QuidelOrtho Corp.'s return on equity of -44.45% beat AtriCure, Inc.'s return on equity of -2.44%.
Company Gross Margin Earnings Per Share Invested Capital QDELQuidelOrtho Corp.37.97% -$1.92 $4.8B ATRCAtriCure, Inc.74.43% $0.04 $568.4M -
What do Analysts Say About QDEL or ATRC?
QuidelOrtho Corp. has a consensus price target of $39.17, signalling upside risk potential of 84.84%. On the other hand AtriCure, Inc. has an analysts' consensus of $49.38 which suggests that it could grow by 59.33%. Given that QuidelOrtho Corp. has higher upside potential than AtriCure, Inc., analysts believe QuidelOrtho Corp. is more attractive than AtriCure, Inc..
Company Buy Ratings Hold Ratings Sell Ratings QDELQuidelOrtho Corp.2 3 0 ATRCAtriCure, Inc.4 2 0 -
Is QDEL or ATRC More Risky?
QuidelOrtho Corp. has a beta of 0.747, which suggesting that the stock is 25.274% less volatile than S&P 500. In comparison AtriCure, Inc. has a beta of 1.423, suggesting its more volatile than the S&P 500 by 42.295%.
-
Which is a Better Dividend Stock QDEL or ATRC?
QuidelOrtho Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AtriCure, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho Corp. pays -- of its earnings as a dividend. AtriCure, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QDEL or ATRC?
QuidelOrtho Corp. quarterly revenues are $723.3M, which are larger than AtriCure, Inc. quarterly revenues of $140.5M. QuidelOrtho Corp.'s net income of -$130.7M is lower than AtriCure, Inc.'s net income of $1.8M. Notably, QuidelOrtho Corp.'s price-to-earnings ratio is -- while AtriCure, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho Corp. is 0.53x versus 2.77x for AtriCure, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QDELQuidelOrtho Corp.0.53x -- $723.3M -$130.7M ATRCAtriCure, Inc.2.77x -- $140.5M $1.8M
-
Which has Higher Returns QDEL or BSX?
Boston Scientific Corp. has a net margin of -18.07% compared to QuidelOrtho Corp.'s net margin of 12.68%. QuidelOrtho Corp.'s return on equity of -44.45% beat Boston Scientific Corp.'s return on equity of 12.55%.
Company Gross Margin Earnings Per Share Invested Capital QDELQuidelOrtho Corp.37.97% -$1.92 $4.8B BSXBoston Scientific Corp.68.5% $0.45 $36.4B -
What do Analysts Say About QDEL or BSX?
QuidelOrtho Corp. has a consensus price target of $39.17, signalling upside risk potential of 84.84%. On the other hand Boston Scientific Corp. has an analysts' consensus of $104.24 which suggests that it could grow by 44.36%. Given that QuidelOrtho Corp. has higher upside potential than Boston Scientific Corp., analysts believe QuidelOrtho Corp. is more attractive than Boston Scientific Corp..
Company Buy Ratings Hold Ratings Sell Ratings QDELQuidelOrtho Corp.2 3 0 BSXBoston Scientific Corp.25 0 0 -
Is QDEL or BSX More Risky?
QuidelOrtho Corp. has a beta of 0.747, which suggesting that the stock is 25.274% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.688, suggesting its less volatile than the S&P 500 by 31.155%.
-
Which is a Better Dividend Stock QDEL or BSX?
QuidelOrtho Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho Corp. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QDEL or BSX?
QuidelOrtho Corp. quarterly revenues are $723.3M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. QuidelOrtho Corp.'s net income of -$130.7M is lower than Boston Scientific Corp.'s net income of $670M. Notably, QuidelOrtho Corp.'s price-to-earnings ratio is -- while Boston Scientific Corp.'s PE ratio is 37.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho Corp. is 0.53x versus 5.38x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QDELQuidelOrtho Corp.0.53x -- $723.3M -$130.7M BSXBoston Scientific Corp.5.38x 37.24x $5.3B $670M
-
Which has Higher Returns QDEL or ISRG?
Intuitive Surgical, Inc. has a net margin of -18.07% compared to QuidelOrtho Corp.'s net margin of 27.89%. QuidelOrtho Corp.'s return on equity of -44.45% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.
Company Gross Margin Earnings Per Share Invested Capital QDELQuidelOrtho Corp.37.97% -$1.92 $4.8B ISRGIntuitive Surgical, Inc.66.41% $2.21 $18.1B -
What do Analysts Say About QDEL or ISRG?
QuidelOrtho Corp. has a consensus price target of $39.17, signalling upside risk potential of 84.84%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $609.82 which suggests that it could grow by 21.68%. Given that QuidelOrtho Corp. has higher upside potential than Intuitive Surgical, Inc., analysts believe QuidelOrtho Corp. is more attractive than Intuitive Surgical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings QDELQuidelOrtho Corp.2 3 0 ISRGIntuitive Surgical, Inc.16 10 1 -
Is QDEL or ISRG More Risky?
QuidelOrtho Corp. has a beta of 0.747, which suggesting that the stock is 25.274% less volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.658, suggesting its more volatile than the S&P 500 by 65.814%.
-
Which is a Better Dividend Stock QDEL or ISRG?
QuidelOrtho Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho Corp. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QDEL or ISRG?
QuidelOrtho Corp. quarterly revenues are $723.3M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.9B. QuidelOrtho Corp.'s net income of -$130.7M is lower than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, QuidelOrtho Corp.'s price-to-earnings ratio is -- while Intuitive Surgical, Inc.'s PE ratio is 63.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho Corp. is 0.53x versus 18.06x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QDELQuidelOrtho Corp.0.53x -- $723.3M -$130.7M ISRGIntuitive Surgical, Inc.18.06x 63.63x $2.9B $799.5M
-
Which has Higher Returns QDEL or ITGR?
Integer Holdings Corp. has a net margin of -18.07% compared to QuidelOrtho Corp.'s net margin of 10.32%. QuidelOrtho Corp.'s return on equity of -44.45% beat Integer Holdings Corp.'s return on equity of 6.11%.
Company Gross Margin Earnings Per Share Invested Capital QDELQuidelOrtho Corp.37.97% -$1.92 $4.8B ITGRInteger Holdings Corp.22.53% $1.38 $3.1B -
What do Analysts Say About QDEL or ITGR?
QuidelOrtho Corp. has a consensus price target of $39.17, signalling upside risk potential of 84.84%. On the other hand Integer Holdings Corp. has an analysts' consensus of $92.63 which suggests that it could grow by 7.67%. Given that QuidelOrtho Corp. has higher upside potential than Integer Holdings Corp., analysts believe QuidelOrtho Corp. is more attractive than Integer Holdings Corp..
Company Buy Ratings Hold Ratings Sell Ratings QDELQuidelOrtho Corp.2 3 0 ITGRInteger Holdings Corp.3 5 0 -
Is QDEL or ITGR More Risky?
QuidelOrtho Corp. has a beta of 0.747, which suggesting that the stock is 25.274% less volatile than S&P 500. In comparison Integer Holdings Corp. has a beta of 0.745, suggesting its less volatile than the S&P 500 by 25.455%.
-
Which is a Better Dividend Stock QDEL or ITGR?
QuidelOrtho Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integer Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho Corp. pays -- of its earnings as a dividend. Integer Holdings Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QDEL or ITGR?
QuidelOrtho Corp. quarterly revenues are $723.3M, which are larger than Integer Holdings Corp. quarterly revenues of $470.9M. QuidelOrtho Corp.'s net income of -$130.7M is lower than Integer Holdings Corp.'s net income of $48.6M. Notably, QuidelOrtho Corp.'s price-to-earnings ratio is -- while Integer Holdings Corp.'s PE ratio is 29.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho Corp. is 0.53x versus 1.64x for Integer Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QDELQuidelOrtho Corp.0.53x -- $723.3M -$130.7M ITGRInteger Holdings Corp.1.64x 29.98x $470.9M $48.6M
-
Which has Higher Returns QDEL or PSTV?
Plus Therapeutics, Inc. has a net margin of -18.07% compared to QuidelOrtho Corp.'s net margin of -316.61%. QuidelOrtho Corp.'s return on equity of -44.45% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital QDELQuidelOrtho Corp.37.97% -$1.92 $4.8B PSTVPlus Therapeutics, Inc.93.84% -$0.04 $5.1M -
What do Analysts Say About QDEL or PSTV?
QuidelOrtho Corp. has a consensus price target of $39.17, signalling upside risk potential of 84.84%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 1682.24%. Given that Plus Therapeutics, Inc. has higher upside potential than QuidelOrtho Corp., analysts believe Plus Therapeutics, Inc. is more attractive than QuidelOrtho Corp..
Company Buy Ratings Hold Ratings Sell Ratings QDELQuidelOrtho Corp.2 3 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is QDEL or PSTV More Risky?
QuidelOrtho Corp. has a beta of 0.747, which suggesting that the stock is 25.274% less volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.788, suggesting its less volatile than the S&P 500 by 21.173%.
-
Which is a Better Dividend Stock QDEL or PSTV?
QuidelOrtho Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho Corp. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QDEL or PSTV?
QuidelOrtho Corp. quarterly revenues are $723.3M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. QuidelOrtho Corp.'s net income of -$130.7M is lower than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, QuidelOrtho Corp.'s price-to-earnings ratio is -- while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho Corp. is 0.53x versus 4.95x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QDELQuidelOrtho Corp.0.53x -- $723.3M -$130.7M PSTVPlus Therapeutics, Inc.4.95x -- $1.4M -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
42
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
93
NBTX alert for Mar 5
Nanobiotix SA [NBTX] is down 5.82% over the past day.
Sell
45
MRNA alert for Mar 5
Moderna, Inc. [MRNA] is down 3.79% over the past day.
Buy
77
SSRM alert for Mar 5
SSR Mining, Inc. [SSRM] is down 6.7% over the past day.
